Foresight Diagnostics to Present Clinical Performance Data on Foresight CLARITY™ MRD at IASLC 2025 World Conference on Lung Cancer

BOULDER, Colo., Sept. 5, 2025 /PRNewswire/ — Foresight Diagnostics, a leader in ultrasensitive minimal residual disease (MRD) detection, today announced an oral presentation in partnership with University Health Network’s (UHN) Princess Margaret Cancer Centre at the IASLC 2025 World…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks